MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q3 2018. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $243,000 | -96.9% | 6,500 | -96.8% | 0.01% | -96.7% |
| Q2 2014 | $7,889,000 | +21.1% | 202,715 | +6.4% | 0.21% | +16.1% |
| Q1 2014 | $6,512,000 | +718.1% | 190,470 | +402.0% | 0.18% | +650.0% |
| Q4 2013 | $796,000 | -58.3% | 37,945 | -53.3% | 0.02% | -59.3% |
| Q3 2013 | $1,909,000 | -2.6% | 81,245 | +11.4% | 0.06% | -3.3% |
| Q2 2013 | $1,959,000 | – | 72,930 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |